Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.

Friedrich Erhart; Tamara Weiss; Simone Klingenbrunner; Katrin Fischhuber; René Reitermaier; Angela Halfmann; Bernadette Blauensteiner; Daniela Lötsch; Sabine Spiegl-Kreinecker; Walter Berger; Fernando J Sialana; Gert Lubec; Thomas Felzmann; Alexander Dohnal; Carmen Visus

doi:10.1016/j.jcyt.2019.03.002

Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.

Friedrich Erhart, Tamara Weiss, Simone Klingenbrunner, Katrin Fischhuber, René Reitermaier, Angela Halfmann, Bernadette Blauensteiner, Daniela Lötsch, Sabine Spiegl-Kreinecker, Walter Berger, Fernando J Sialana, Gert Lubec (Co-author), Thomas Felzmann, Alexander Dohnal, Carmen Visus

Research output: Contribution to journal › Original Article › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	643-658
Journal	CYTOTHERAPY
Volume	21
Issue number	6
DOIs	https://doi.org/10.1016/j.jcyt.2019.03.002
Publication status	Published - 2019

Keywords

CANCER STEM-CELLS
INITIATING CELLS
PHASE-I
GROWTH
TEMOZOLOMIDE
VACCINATION
POPULATION
EXPRESSION
EXPANSION
GLIOMAS

Access to Document

10.1016/j.jcyt.2019.03.002

Cite this

Erhart, F., Weiss, T., Klingenbrunner, S., Fischhuber, K., Reitermaier, R., Halfmann, A., Blauensteiner, B., Lötsch, D., Spiegl-Kreinecker, S., Berger, W., Sialana, F. J., Lubec, G., Felzmann, T., Dohnal, A., & Visus, C. (2019). Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production. CYTOTHERAPY, 21(6), 643-658. https://doi.org/10.1016/j.jcyt.2019.03.002

@article{530129e8dbc34afc9e776c04421c7cad,

title = "Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.",

keywords = "CANCER STEM-CELLS, INITIATING CELLS, PHASE-I, GROWTH, TEMOZOLOMIDE, VACCINATION, POPULATION, EXPRESSION, EXPANSION, GLIOMAS",

author = "Friedrich Erhart and Tamara Weiss and Simone Klingenbrunner and Katrin Fischhuber and Ren{\'e} Reitermaier and Angela Halfmann and Bernadette Blauensteiner and Daniela L{\"o}tsch and Sabine Spiegl-Kreinecker and Walter Berger and Sialana, \{Fernando J\} and Gert Lubec and Thomas Felzmann and Alexander Dohnal and Carmen Visus",

year = "2019",

doi = "10.1016/j.jcyt.2019.03.002",

language = "English",

volume = "21",

pages = "643--658",

journal = "CYTOTHERAPY",

issn = "1465-3249",

publisher = "Taylor \& Francis ",

number = "6",

}

Erhart, F, Weiss, T, Klingenbrunner, S, Fischhuber, K, Reitermaier, R, Halfmann, A, Blauensteiner, B, Lötsch, D, Spiegl-Kreinecker, S, Berger, W, Sialana, FJ, Lubec, G, Felzmann, T, Dohnal, A & Visus, C 2019, 'Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.', CYTOTHERAPY, vol. 21, no. 6, pp. 643-658. https://doi.org/10.1016/j.jcyt.2019.03.002

Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production. / Erhart, Friedrich; Weiss, Tamara; Klingenbrunner, Simone et al.
In: CYTOTHERAPY, Vol. 21, No. 6, 2019, p. 643-658.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.

AU - Erhart, Friedrich

AU - Weiss, Tamara

AU - Klingenbrunner, Simone

AU - Fischhuber, Katrin

AU - Reitermaier, René

AU - Halfmann, Angela

AU - Blauensteiner, Bernadette

AU - Lötsch, Daniela

AU - Spiegl-Kreinecker, Sabine

AU - Berger, Walter

AU - Sialana, Fernando J

AU - Lubec, Gert

AU - Felzmann, Thomas

AU - Dohnal, Alexander

AU - Visus, Carmen

PY - 2019

Y1 - 2019

KW - CANCER STEM-CELLS

KW - INITIATING CELLS

KW - PHASE-I

KW - GROWTH

KW - TEMOZOLOMIDE

KW - VACCINATION

KW - POPULATION

KW - EXPRESSION

KW - EXPANSION

KW - GLIOMAS

U2 - 10.1016/j.jcyt.2019.03.002

DO - 10.1016/j.jcyt.2019.03.002

M3 - Original Article

C2 - 30975602

SN - 1465-3249

VL - 21

SP - 643

EP - 658

JO - CYTOTHERAPY

JF - CYTOTHERAPY

IS - 6

ER -